Category

News Brief

UF Neuro Research Ranks No. 2 Nationally in NIH Funding

Neuroscience and neuromedicine research at the University of Florida ranked No. 2 in NIH funding among all public universities in the U.S., according to the Blue Ridge Institute for Medical Research’s 2023 rankings. With $31.8 million in NIH funding, UF neurosciences — a combined ranking of the departments of neuroscience and neurology — ranked No. 2 among public universities and No. 3 overall. In 2022, UF neurosciences ranked No. 3 among public universities and No. 5 overall.

Tech Tuesday – Felipe Ferrão

In this week’s Tech Tuesday for WCJB TV20, UF Innovate’s Loren Miranda speaks with Felipe Ferrão, associate research scientist the University of Florida Institute of Food and Agricultural Sciences finding ways to make coffee a go-to crop for Florida farmers.

Canaery-Led Research Team Funded by US National Science Foundation Convergence Accelerator

UF Innovate | Accelerate resident client Canaery, the neurotech company revolutionizing the detection of important scents in real-world settings, announced it has secured $650,000 in Phase 1 funding from the U.S. National Science Foundation (NSF) Convergence Accelerator leading an interdisciplinary team of scientists, engineers, and operators. Teams that complete Phase 1 may qualify for up to $5 million in Phase 2 funding.

Decoding the Genes Behind Dolastatin 10 Paves the Way for New Cancer Therapeutics

Researchers at the University of Florida College of Pharmacy have identified the genes responsible for the creation of dolastatin 10, a marine natural product that has led to six FDA-approved cancer drugs since 2011. The research team used genomic library screening and genome sequencing to identify the genes responsible for producing the marine natural product.

Novel Compound Opens New Avenue in Immunotherapy Treatment for Cancers

Researchers at the UF Health Cancer Center have developed a first-of-it-kind compound that may reveal a new way to treat cancer using immunotherapy. Currently, immunotherapy is among the most groundbreaking cancer treatments, but only about 20% to 40% of patients respond to it. It works by first identifying a target protein that contributes to tumor development and then developing a compound that will target that protein specifically, slowing tumor growth and boosting the body's immune system to fight off the cancer.

Christine Schmidt elected to National Academy of Engineering

UF Distinguished Professor Christine Schmidt, Ph.D., has been elected to the National Academy of Engineering. Dr. Schmidt has been working in the field for over 25 years, helping to advance the fields of neural tissue engineering and helping diversify the field of bioengineering. Serving for 10 years as the department chair in the J. Crayton Pruitt Family Department of Biomedical Engineering, Dr. Schmidt pushed the UF BME graduate program to the No. 12 ranked public graduate program in the nation while diversifying the program and producing cutting-edge research.

UF/IFAS Scientists Address Food Security in the Caribbean

Jehangir 'Jango' Bhadha, associate professor of soil, water, and ecosystem sciences at the University of Florida Institute of Food and Agricultural Sciences (UF/IFAS), recently led a team of faculty during a three-day training program in Saint Vincent and the Grenadines to address the challenges of excess and lack of nutrients used for agricultural production.